Blog

VANCOUVER, BC / ACCESS Newswire / June 2, 2025 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce the completion of the amended Membership Interest Purchase Agreement (the “MIPA”) entered into by its wholly owned subsidiary, FN Pharmaceuticals, and Mr. Caleb Zobrist (the “Seller”) to acquire his nine percent (9%) of the issued and outstanding membership interests of Alternative Medicine Association LC (“AMA”) (refer to news releases dated April 8, 2024 and May 22, 2025). The transaction closed on May 30, 2025.

With the completion of the MIPA, FN Pharmaceuticals now owns 100% of the membership interest in AMA, the Company’s cultivation and production subsidiary.

Under the amended MIPA, the purchase price (the “Purchase Price”) for the Membership is a total of USD$50,00, payable to the Seller USD$25,000 in cash and USD$25,000 through the issuance of shares of common stock of 1933 Industries (the “Shares”). The final number of Shares to be issued to the Seller is 5,503,450 as determined via the 10 day VWAP price of the Shares on November 27, 2024, being the date the transactions contemplated by the MIPA were approved by the Nevada Cannabis Compliance Board.

The Shares are subject to a hold period in Canada expiring on October 1, 2025. Additional restrictions will apply pursuant to the Securities Act of 1933, as amended.

As Mr. Zobrist was a senior officer of the Company at the time the MIPA was entered into, he is a “related party” to the Company within the meaning of Multilateral Instrument 61-101- Protection of Minority Security Holders in Special Transactions (“MI 61-101”). As such, the transaction constitutes a “related party transaction” within the meaning of MI 61-101.

The Company intends to rely on exemptions from formal valuation and the minority shareholder approval requirements of MI 61-101 found in sections 5.5(a) and 5.7(1)(a) of MI 61-101 as the fair market value of the transaction does not constitute more than the 25% of the Company’s market capitalization.

About 1933 Industries Inc.

1933 Industries is a Nevada-based licensed wholesale producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company’s 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com

For further information please contact:
Alexia Helgason, VP, Investor Relations
604-728-4407
alexia@1933industries.com

Brian Farrell, Chairman and CEO
brian@1933industries.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: 1933 Industries Inc.

View the original press release on ACCESS Newswire

A Universal Search Experience That Brings Speed, Simplicity, and Context to Business Intelligence

SAN FRANCISCO, CA / ACCESS Newswire / June 2, 2025 / GoodData, the AI-native analytics platform, today introduced AI Smart Search, an intelligent search experience designed to help users instantly locate analytics content across their workspace. Whether it’s a dashboard, visualization, or saved insight, Smart Search eliminates the guesswork of navigation and puts the right information at your fingertips, within seconds.

By combining modern UX patterns with AI-powered semantic understanding, this new feature brings the ease of consumer-grade search tools to enterprise analytics. From quick lookups to deep discovery, Smart Search is built to support everyone, from data-savvy professionals to analytics engineers, making it easier than ever to find, reuse, and explore what already exists in your analytics environment.

Search Anything. Instantly. Intelligently.

With a single keystroke, users can access a global search bar embedded in the main workspace navigation. This AI-native feature goes beyond keyword matching – it uses vector-based semantic similarity to surface the most relevant results based on names, descriptions, and tags.

Key Capabilities Include:

• Semantic Matching: Understands the meaning behind your query to deliver relevant dashboards, visualizations, and metrics, even when the phrasing isn’t exact (e.g., searching for “monthly revenue trends” can return insights titled “Revenue over time” or “Monthly sales growth”).

• Contextual Previews: Each result includes metadata like object type, last edited timestamp, and confidence score.

• Real-Time Feedback: Results appear after typing each character, updating dynamically without needing to press Enter.

• Historical Recall: Shows recent searches by default, helping users return to past explorations quickly.

• Accessible Navigation: Fully keyboard-operable, navigate with arrows, select with Enter, exit with Esc, and more, for an inclusive and efficient experience.

• Permission-Aware Results: Users see only what their access level allows, ensuring privacy and compliance across roles.

AI-Powered Architecture

Under the hood, GoodData AI Smart Search is built on a scalable and secure foundation that ensures speed and precision at scale:

• Distributed Qdrant Vector Store: Provides high availability and auto-scalability for fast and reliable search performance across enterprise environments.

• Multi-Lingual Small Language Model: Generates embeddings for semantic layer entities in near-real-time, enabling support for diverse language inputs.

• Advanced Re-Ranking Algorithms: Multiple language models are used to re-rank search results, optimizing for the most contextually relevant answers.

• Fully Embedded, Perimeter-Secure Deployment: All processing is handled within the GoodData platform boundary, so no data ever leaves your secure environment. This applies to any deployment type – on-prem or in GoodData Cloud.

“GoodData AI Smart Search brings the intelligence of AI and the familiarity of modern search UX into enterprise analytics,” said Jan Franek, Senior Product Manager at GoodData. “It’s not just about finding dashboards-it’s about accelerating insight discovery while reducing duplication and friction.”

For All Users-from Prosumers to Power Builders

• Business Users: Skip creating new reports-find existing answers fast.

• Analytics Engineers: Locate elements to edit, reuse, or integrate in seconds.

• Developers: Embed Smart Search into custom applications for a tailored, white-labeled user experience.

Composable Search for Every Workflow

GoodData AI Smart Search is designed for flexibility, whether used as a native feature within the GoodData platform or integrated into your own applications. Thanks to GoodData’s composable architecture, businesses can embed the search experience via APIs and SDKs, delivering fast, contextual insight discovery directly within their workflows. It’s a powerful extension of the AI ecosystem, ensuring consistency, security, and scalability from the ground up.

Looking Ahead

GoodData AI marks the beginning of a new era of BI, where AI isn’t just a bolt-on assistant but a core, intelligent layer within the analytics stack. As the platform evolves, expect deeper orchestration and integration, and more intuitive user experiences, delivered at scale, securely, and in full alignment with enterprise needs.

AI Smart Search is one of the first major milestones in this journey along with GoodData AI Assistant – an interactive, conversational interface that helps users generate insights, build dashboards, and interpret data using natural language. Together, these capabilities represent a fundamental shift toward a more intelligent, context-aware analytics experience.

AI will continue expanding across every layer of the GoodData platform, powering intelligence everywhere it’s needed.

---

About GoodData

GoodData is the AI-native analytics platform built for speed, scale, and trust, helping companies deliver real-time insights – embedded, branded, and everywhere your users need them.

Founded in 2007, and with offices in both the U.S. and Europe, GoodData serves over 140,000 of the world’s top companies and 3.2 million users, helping them drive meaningful change and maximize the value of their data.

For more information, visit GoodData’s website and follow GoodData onLinkedIn, YouTube, and Medium.

GoodData Contact

press@gooddata.com

©2025, GoodData Corporation. All rights reserved. GoodData and the GoodData logo are registered trademarks of GoodData Corporation in the United States and other jurisdictions. Other names used herein may be trademarks of their respective owners.

SOURCE: GoodData

View the original press release on ACCESS Newswire

Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human dosing in the first half of 2026

MIAMI, FL / ACCESS Newswire / June 2, 2025 / Telomir Pharmaceuticals, Inc. (Nasdaq:TELO) (“Telomir” or the “Company”), an emerging leader in age-reversal science, today announced its participation in the BIO International Convention 2025, taking place in Boston, MA from June 16-19, 2025. The Company has scheduled a full week of BIO One-on-One Partnering™ meetings to explore strategic collaborations, licensing opportunities, and potential M&A transactions.

Telomir is actively preparing to submit an Investigational New Drug (IND) application by the end of this year for its lead candidate, Telomir-1-a novel small molecule designed to elongate telomeres, regenerate cells, and reverse core mechanisms of biological aging. The Company is gearing up for its pre-IND meeting with the FDA, with the goal of initiating first-in-human dosing in the first half of 2026.

As part of its expanding pipeline, Telomir is advancing a rare-disease exploratory and developmental strategy focused on high-need orphan indications where cellular aging plays a central role. These include:

• Werner’s syndrome, a rare adolescent- or adult-onset disorder often referred to as “adult Progeria,” which is expressed by many features of premature aging, including early graying, cataracts, metabolic dysfunction, and cancer predisposition.

• Wilson’s disease, a rare genetic disorder caused by copper accumulation in tissues. Telomir-1 has already demonstrated in preclinical testing copper-modulating capabilities, reversal of copper-induced toxicities and reactive oxygen species production, offering a potential disease-modifying approach that directly addresses the root cause of toxicity and inflammation associated with Wilson’s.

• Progeria, an ultra-rare pediatric condition that causes rapid aging in children, where Telomir-1 has shown in animal models restoration of lifespan and normalization of disease markers.

• Dysphonia, including rare neuromuscular subtypes that impair vocal cord function and may be linked to inflammation and accelerated tissue degeneration.

The Company plans to meet with the FDA to establish novel clinical endpoints across its rare disease programs, aiming to unlock accelerated development pathways and regulatory flexibility.

In parallel, Telomir-1 is also being investigated in autism spectrum disorder, where its potential impact on telomere biology, oxidative stress, neurodegeneration and inflammation may offer a novel therapeutic approach for neurodevelopmental conditions.

Beyond rare and neurological disorders, Telomir has achieved significant preclinical success across a range of high-impact therapeutic areas, underscoring the versatility of its platform:

• Vision Restoration: Structural and functional recovery of the retina in FDA-recognized endpoints in animal models of age-related macular degeneration (AMD).

• Longevity and Aging: Consistent age-reversal, increased lifespan, and improved health in standard aging, Werner’s syndrome and in Progeria models.

• Metabolic Disease: In preclinical models of Type 2 diabetes,Telomir-1 led to the reversal of elevated blood glucose, restoration of insulin sensitivity, improved pancreatic islet function, and a marked reduction in oxidative stress and systemic inflammation.

• Oncology: In a preclinical model of aggressive human prostate cancer, Telomir-1 alone at both low and high doses reduced tumor growth by approximately 50%, while also exhibiting a protective effect on healthy cells. These findings directly counter concerns that telomere-elongating drugs may promote cancer; instead, Telomir-1 actively suppressed tumor progression.

• Infectious Disease: Development of Telomir-Ag2, a novel drug candidate with potent activity against multidrug-resistant bacteria, including MRSA.

“The breadth of our preclinical data showcases the potential of Telomir-1 not just as a treatment-but as a platform for addressing aging-related and rare diseases at the source,” said Erez Aminov, Chief Executive Officer of Telomir. “As we prepare for IND submission and for a pre-IND meeting with the FDA, we look forward to connecting with potential partners at BIO to explore licensing and M&A opportunities that can help accelerate our path to the clinic.”

Dr. Angel, Chief Scientific Advisor at Telomir, added:
“In all my years in drug development, I’ve never seen a molecule with this kind of cross-indication potential. The science behind Telomir-1 is remarkable-it’s addressing cellular aging at its root, and the preclinical data speak for themselves. What excites me most is how this one molecule may have the power to transform how we treat aging-related, metabolic, and rare genetic diseases across the board.”

Cautionary Note Regarding Forward-Looking Statements

This press release, statements of Telomir’s management or advisors related thereto, and the statements contained in the news story linked in this release contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications, and the safety of Telomir-1.

Any forward-looking statements in this press release are based on Telomir’s current expectations, estimates and projections only as of the date of this release. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications and safety of Telomir-1. These and other risks concerning Telomir’s programs and operations are described in additional detail in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is on file with the SEC. Telomir explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

Contact Information

Helga Moya
info@telomirpharma.com
(786) 396-6723

SOURCE: Telomir Pharmaceuticals, Inc

View the original press release on ACCESS Newswire

IRS Debt Doesn’t Just Lead to Penalties – It Can Derail Major Life Goals, Warns Clear Start Tax

IRVINE, CA / ACCESS Newswire / June 2, 2025 / For many Americans, back taxes may seem like a personal issue, but the consequences extend far beyond IRS notices. According to Clear Start Tax, a nationally recognized tax resolution firm, unpaid tax debt can severely damage your credit, block financial opportunities, and create lasting setbacks that impact everything from buying a home to securing a loan or job.

“People think of the IRS as separate from their financial reputation,” said the Head of Client Solutions at Clear Start Tax. “But a tax lien or collection activity can hit your credit and your long-term goals harder than you expect.”

What Ignoring Back Taxes Could Really Cost You

Failing to address back taxes doesn’t just leave you with a growing balance – it opens the door to enforcement actions that can affect your income, assets, and long-term financial health. As Clear Start Tax explains, IRS collection efforts often begin quietly but can escalate quickly and aggressively if left unresolved. Some of the most serious consequences include:

• Tax liens can be filed against your property and reported to credit bureaus, reducing credit scores and limiting your ability to borrow.

• Bank levies can drain your accounts with little warning, leaving you without access to needed funds.

• Wage garnishments can reduce your take-home pay and create a cycle of financial instability.

• Interest and penalties compound daily, quickly increasing what you owe.

Clear Start Tax notes that these consequences don’t just harm your current finances – they also delay or destroy future plans, including mortgage approvals, car loans, small business funding, and even job applications with financial background checks.

Credit Damage Can Linger Long After the Tax Is Paid

Even after a tax debt is resolved, the financial damage can linger. Public records like tax liens (when reported) and collection actions can remain on credit reports for years. And if a taxpayer entered into a payment plan late-or only after enforcement began-that history may still reflect negatively in the eyes of lenders or employers.

“Back taxes aren’t just a balance to pay-they can become a barrier to progress,” added the Head of Client Solutions at Clear Start Tax. “We’ve worked with clients who couldn’t refinance their homes or qualify for financing because of unresolved tax issues that were years old.”

How Clear Start Tax Helps Clients Protect Their Credit and Rebuild Confidence

Clear Start Tax offers personalized solutions that do more than just address the debt-they help safeguard credit and prevent long-term damage. The firm works with each client to:

• Conduct a full IRS and credit risk review

• Recommend the right IRS program (such as Offer in Compromise, Installment Agreement, or CNC status)

• Prevent or remove liens and stop garnishments

• Ensure timely filings to maintain eligibility for relief

• Provide guidance on staying compliant to rebuild financial health

With the right strategy and early action, most taxpayers can avoid the worst outcomes and take back control of their financial future.

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

SYDNEY, AUSTRALIA / ACCESS Newswire / June 2, 2025 / Dateline Resources Limited (ASX:DTR)(OTC:DTREF) announces an update on its 100%-owned Colosseum Gold and Rare Earth Element (REE) Project in California, detailing recent exploration findings and planned activities for 2025. Recent geological mapping and data analysis indicate the potential for the project’s known resources to be significantly larger, based on evidence of a potentially broader mineralized system.

The Colosseum Project has a JORC-2012 compliant Mineral Resource of 27.1 million tons at 1.26 g/t gold, totaling 1.1 million ounces, with 455,000 ounces classified as Measured, 281,000 ounces as Indicated, and 364,000 ounces as Inferred. An economic assessment announced on May 23, 2025, reported an NPV of US$550 million and an IRR of 61% at a gold price of US$2,900/oz.

Recent re-examination of 2023 gravity survey data, cross referenced with new geochemical results, shows that gravity low anomalies align with the historically mined North and South breccia pipes and newly identified felsite outcrops located 200-900 meters west and southwest of the previously mined pits. This correlation suggests the presence of additional breccia pipes, which could host further gold mineralization. The data supports an interpretation of the Colosseum deposit as a larger breccia pipe complex, with the mined pipes potentially representing only the upper, eroded portions of a more extensive system.

Figure 1: Cross-section A-A′ (looking approximately north) showing the drilled Colosseum breccia pipe (blue volume) cantered within a pronounced gravity low (light blue colour) and recently sampled felsite dykes (red arrows) to the west also sit in gravity lows.

To further define this potential, Dateline will commence a comprehensive exploration program in June 2025. A four-week soil geochemical survey will collect samples across the project area on systematic grids to identify gold, REE, and pathfinder element anomalies. Concurrently, a magneto telluric (MT) geophysical survey will begin in late June to map subsurface structures and potential REE-bearing carbonatite bodies. These surveys will provide complementary datasets to refine drill targets. Dateline’s technical team will integrate gravity, geochemical, and MT data to prioritize areas where these indicators converge, enhancing the likelihood of identifying potential mineralized zones.

Figure 2: Plan view map showing gravity data overlaid with proposed soil sampling locations (purple dots at 60 m spacing). The mined North and South breccia pipes lie within a central gravity low (blue), while newly sampled felsite outcrops on the western margin also coincide with a gravity low. Two circular gravity lows to the east of the pits represent untested potential breccia pipe targets. The soil sampling program is designed to geochemically test all these features to support vectoring for both gold and REE mineralisation

A dedicated REE drilling program is being finalized to test high-priority targets, including depth extensions of REE-bearing fenite/trachyte dykes and coincident gravity-MT anomalies. Drilling will also probe for extensions of the known gold-bearing breccia pipes and newly indicated targets. The program, supported by REE geologists Dr. Tony Mariano and Tony Mariano Jr., aims to confirm the presence and scale of additional gold and REE mineralization.

The Colosseum Project is located in the Walker Lane Trend, less than 10km from the Mountain Rare Earth mine, positioning it favorably for REE exploration. The combination of existing resources, new geological insights, and planned exploration supports the potential for significant resource growth.

About Dateline Resources Limited

Dateline Resources Limited (ASX:DTR) is an Australian publicly listed company focused on high-value mining and exploration in North America. The Colosseum REE and Gold Project, located in California’s Walker Lane Trend, is a flagship asset with emerging REE potential and proven gold resources.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or future performance and include, but are not limited to, statements regarding the potential of the Colosseum Project, the expected benefits of the OTCQB listing, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on the company’s current expectations, estimates, and projections, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to: fluctuations in the prices of gold and rare earth elements; changes in regulatory requirements or permitting processes; geological or technical challenges in exploration and development; market conditions affecting the company’s ability to raise capital; environmental or social factors impacting operations; risks associated with the OTCQB listing process or trading on a new market; environmental and permitting risks associated with operating in a national preserve; uncertainty regarding the delineation of a mineable rare earth elements resource; risks related to the company’s ability to secure necessary funding for project development; and potential changes in government policies or priorities affecting the critical minerals sector. The company cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company does not undertake any obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Competent Person Statement

The exploration data has been reviewed by Mr. Greg Hall, a Chartered Professional of the Australasian Institute of Mining and Metallurgy (CP-IMM) and Non-Executive Director of Dateline. Mr. Hall, with extensive experience in IRGS-style mineralization, qualifies as a Competent Person under the JORC Code and consents to the inclusion of this information.

Contact Information

For further details, please contact:

• Stephen Baghdadi, Managing Director, +61 2 9375 2353, www.datelineresources.com.au

• Andrew Rowell, White Noise Communications, +61 400 466 226, andrew@whitenoisecomms.com

Follow Dateline on X: @Dateline_DTR

This announcement is authorized for release by the Dateline Resources Limited Board of Directors.

SOURCE: Dateline Resources Limited

View the original press release on ACCESS Newswire

BOCA RATON, FL / ACCESS Newswire / June 2, 2025 / Newsmax Inc. (NYSE:NMAX) (“Newsmax” or the “Company”) today announced that the Company expects to list on the U.S. small-cap Russell 2000^® Index, effective after the U.S. market opens on June 30, 2025, as part of the 2025 Russell indexes reconstitution.

Membership in the Russell 3000^® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000^® Index or small-cap Russell 2000^® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

“The past year has been transformational for Newsmax, and we are pleased to see our shares will soon be added to the Russell 2000® Index, one of the market’s leading performance benchmarks in North America,” said Chris Ruddy, CEO of Newsmax.

Newsmax, a television and digital media company offering Americans independent news, went public on the NYSE in March.

Since then, Newsmax has made several major announcements, including expanded cable / pay TV distribution on Hulu+, putting Newsmax into top-tier penetration of around 60 million U.S. homes.

“We feel this addition of Newsmax on the Russell Index will help raise awareness and ownership of Newsmax within the institutional investment community,” continued Ruddy.

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell’s U.S. indexes. Russell indexes are also part of FTSE Russell, a leading global index provider.

About Newsmax

Newsmax Media, Inc. operates Newsmax, the nation’s fourth highest-rated cable news network, according to Nielsen. Newsmax is carried on all major cable, satellite systems, and virtual pay TV operators. Newsmax reaches more than 40 million Americans regularly through Newsmax TV, the Newsmax+ App, its popular website Newsmax.com, and publications like Newsmax Magazine. Reuters Institute says Newsmax is one of the top 12 U.S. news brands and Forbes has called us “a news powerhouse.”

For more information, please visit Investor Relations | Newsmax Media, Inc.

About FTSE Russell, an LSEG Business

FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering.

FTSE Russell is wholly owned by London Stock Exchange Group.

For more information, visit FTSE Russell.

Forward-Looking Statements

This communication contains forward-looking statements. From time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Forward-looking statements can be identified by those that are not historical in nature. The forward-looking statements discussed in this communication and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. Newsmax does not guarantee future results, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. Forward-looking statements should not be relied upon as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this communication to conform our prior statements to actual results or revised expectations, and we do not intend to do so. Factors that may cause actual results to differ materially from current expectations include various factors, including but not limited to any changes in indications we have received from FTSE Russell regarding inclusion in certain indexes, our ability to change the direction of Newsmax, our ability to keep pace with new technology and changing market needs, the competitive environment of our business changes in domestic and global general economic and macro-economic conditions and/or uncertainties and factors set forth in the sections entitled “Risk Factors” in Newsmax’s Annual Report on Form 10-K for the twelve months ended December 31, 2024, Newsmax’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025, and other filings Newsmax makes with the Securities and Exchange Commission. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. Undue reliance should not be placed on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein.

Investor Contacts

Newsmax Investor Relations
ir@newsmax.com

SOURCE: Newsmax Inc.

View the original press release on ACCESS Newswire

All AstroNova Stakeholders Invited to Meet and Interact with Askeladden’s Board Candidates

Askeladden Nominees Have Specific and Relevant Expertise to Execute Askeladden’s Plan to Maximize Value

Transdigm’s Recently Raised Bid for Aerospace Components Company Servotronics Highlights Potential to Unlock Value at AstroNova with Better Governance

FORT WORTH, TX / ACCESS Newswire / June 2, 2025 / Dear AstroNova stakeholders:

I write to you as the founder and portfolio manager of Askeladden Capital (collectively, “we,”) which is AstroNova’s largest shareholder, owning approximately 9.2% of the company on behalf of our clients.

In an effort to improve AstroNova’s performance for the benefit of shareholders, employees, and all other stakeholders, we have nominated five highly qualified individuals for election to AstroNova’s Board of Directors at the company’s Annual Meeting, scheduled for July 9, 2025.

We invite you to join an Investor Forum where shareholders, employees, and all other interested parties can interact directly with our nominees. After a brief introduction and panel discussion of approximately 20 minutes, we will open up the call for Q&A.

We will conduct this “town hall” style meeting virtually via Zoom at 11:00 AM Eastern Time (10:00 AM Central Time) on Thursday, June 12, 2025. You can register here :

https://zoom.us/webinar/register/WN_P4nfq0iOSamSBEiaDZ0IZA#/registration

Please contact Samir Patel via samir@askeladdencapital.com if you have any trouble registering.

Attendees will have the option to remain anonymous to all parties other than the host. Those who cannot attend live are also invited to email us with written questions that we will read and answer during the town hall as time permits. A recording of the call will subsequently be made available.

We encourage candid and detailed questions – the more challenging the better – about our research, our plan, our nominees’ backgrounds, and how we will work as a team to maximize the value of AstroNova for all. Please ask similar questions of the incumbents, then vote based on whose answers you find more compelling.

Askeladden has researched AstroNova since 2016 and been a 5% shareholder since 2020. Since March, we have spoken to over 15 individuals, ranging from former employees to suppliers and other industry veterans, to deepen our understanding of the company. In the near future, we will share selected research findings with AstroNova shareholders.

We believe AstroNova has many strengths, such as a large installed base and many talented employees. Unfortunately, we believe that these attractive qualities have been overwhelmed by poor governance and management by the incumbent Board, and CEO Greg Woods, which has harmed shareholders and employees alike. In FY2025, the company reported Adjusted EBITDA of $12.3 million, substantially below FY2024’s $17.6 million and FY2025 original guidance of ~$21 million at the midpoint. [1]

The company’s May 2024 acquisition of MTEX should have further enhanced profitability – instead, the CEO and Board’s decision to spend $18.7 million in cash and assume additional debt [2] to fund this acquisition harmed both shareholders and employees. The share price fell almost 50% over the ensuing year, [3] while employees have faced layoffs. [4]

In FY2025, MTEX generated an operating loss of $16.9 million, including a goodwill impairment of $13.4 million, and the company subsequently discontinued 70% of MTEX’s product portfolio. [5] [6]

As a result of the lower earnings and increased debt due to the MTEX acquisition, the company breached its debt covenants and suffered an event of default under its credit facility during the quarter ended January 31, 2025 (thus forcing AstroNova to seek a waiver from its lender, which was subsequently granted). [7]

While CEO Greg Woods retains his job despite this self-inflicted debacle, many AstroNova employees were not so lucky: on March 20, 2025, the company announced “the reduction of approximately 10% of the Company’s global workforce, primarily in the PI [Product Identification] segment.” [8] Through no fault of their own, rather than enjoying the profit-sharing and career growth opportunities that a well-managed company should provide, 10% of AstroNova employees lost their jobs.

Despite these missteps, incumbents appear to be doubling down on this failed strategy, and have refused to engage with Askeladden’s efforts to improve the company’s performance.

We recently published a 20-page document including our specific, research-based plan for improving AstroNova’s performance, as well as relevant background information on the company’s performance and governance. We believe that our nominees have specific and relevant qualifications to address the current challenges faced by AstroNova. Below is their biographical information.

Shawn Kravetz. Mr. Kravetz has relevant experience as a change agent under similar circumstances. He joined the Board of Nevada Gold & Casinos, Inc. as a large shareholder frustrated by performance, including a recent acquisition. He served from 2016 until Nevada Gold was sold in 2019, including Chairman of the Corporate Governance and Nominating Committee. Mr. Kravetz was recently nominated for election to the Board of publicly traded Spruce Power Holding Corporation by the company’s Nominating and Governance Committee. [9]

Jeff Sands. As Mr. Sands discusses in his book, “Corporate Turnaround Artistry: Fix Any Business in 100 Days,” he has successfully used techniques included in our plan to restore profitability at numerous businesses, including some merely weeks away from lender-forced liquidation. He has won the Turnaround Management Association “Turnaround of the Year” award three times. Mr. Sands has successfully worked with businesses such as a $100M supplier of aerospace components to Boeing (~2x the size of AstroNova’s Aerospace segment), as well as complex and capital-intensive businesses such as steel and pharmaceuticals. Given AstroNova’s significant recent decline in profitability and elevated inventory balances, Mr. Sands’ experience in driving rapid cash flow improvement is extremely relevant. Mr. Sands has been involved in the sale of numerous private companies.

Ryan Oviatt. Mr. Oviatt has extensive experience – as CFO, CEO, and Board Member of Profire – of managing an industrial products business for margin and cash flow in the highly cyclical energy market. Mr. Oviatt managed a team that used techniques such as automation of manual processes and key administrative functions, customer outreach, and performance-based incentive compensation programs designed to instill a sense of ownership throughout the company. Mr. Oviatt helped lead the successful sale of Profire to a strategic public-company buyer, CECO Environmental. After multiple rounds of negotiation, Profire successfully achieved a final offer price 27.5% higher than CECO’s original offer, and an all-cash deal rather than the original offer of 75% cash and 25% stock. This final offer represented a 60.3% premium to Profire’s volume-weighted average share price over the 30 days prior to the Board approving the merger. ^[10]

Boyd Roberts. Mr. Roberts was the youngest member of the executive team at Franklin Covey (FC) and has integrated and substantially grown an acquired division, with ownership of full P&Ls and high employee net promoter scores. Mr. Roberts has extensive experience with Franklin Covey’s customer-focused recurring-revenue business model. Mr. Roberts is fluent in Portuguese. His linguistic and cultural strengths uniquely qualify him to address the challenging MTEX acquisition, which we believe has suffered due to a cultural mismatch between the labor force at its facility in Porto in northern Portugal, and AstroNova’s American business culture. [11]

Samir Patel. As AstroNova’s largest shareholder, who has researched the business since 2016, I am deeply familiar with the company’s ongoing (flawed) strategy, contrary to the company’s misleading assertion that the company will be damaged by a new Board “unacquainted with recent decision-making .” [12] I will ensure that AstroNova’s operational and capital allocation decisions consistently maximize shareholder value.

As a point of comparison on what AstroNova could potentially be worth with better governance, we note that Servotronics (SVT), a global designer and manufacturer of servo controls and other components for aerospace and defense applications, announced a merger with large aerospace manufacturer Transdigm (TDG) for $110 million in cash on May 19, 2025, and subsequently raised the offer price by ~22% from $38.50 to $47.00 after Servotronics received another offer from a competing bidder, suggesting significant interest in the business at that valuation. [13] Even the original offer price – let alone the subsequent increase – is almost identical to AstroNova’s entire enterprise value as of May 20, 2025. ^{[14] [15]}At the original offer price, the all-cash transaction represented a 274% premium to Servotronics’ share price at the prior close. For the fiscal year 2024, Servotronics generated $44.9 million in revenue with only $8.2 million in gross profit and less than $1 million in Adjusted EBITDA. ^[16]

Meanwhile, for its FY2025 which ended a month later, AstroNova’s Test and Measurement segment (subsequently renamed Aerospace) generated a slightly higher $48.9 million in revenues with a much higher $11.1 million in segment operating profit. It seems reasonable to assume that a buyer evaluating these two businesses side by side would assign a higher valuation to AstroNova Aerospace given its modestly higher revenues and substantially higher profits. In other words (and apart from any tax considerations), that would imply that if AstroNova Aerospace was sold at a similar value to Servotronics’ original agreement – let alone the higher subsequent agreement raising the offer amount by over 20% – AstroNova could pay off all its debt and return cash to shareholders equivalent to roughly the current share price. Shareholders would then still own the entire Product Identification segment, with slightly over $100 million in annual revenues generated each of the past three fiscal years, which is clearly worth substantially more than the zero or even negative value implied if Servotronics’ valuation is applied to AstroNova Aerospace. [17]

While the Servotronics transaction is merely one data point, it demonstrates the potential value if AstroNova implements the strategy we have developed – which we recently presented in our public plan – rather than doubling down on a strategy promoted by the value-destroying incumbent CEO and Board. In the more than eleven years from February 1, 2014 (when Mr. Woods became CEO) through May 15, 2025 (the record date of this year’s Annual Meeting), AstroNova shares have experienced a total return of negative 28%. [18]

You can find further information about the upcoming board election, scheduled for July 9, 2025, at the AstroNova page on the Askeladden Capital website : https://www.askeladdencapital.com/astronova/

These documents will also be available at no cost at www.sec.gov .

As stated previously, the “town hall” will occur virtually via Zoom at 11:00 AM Eastern Time (10:00 AM Central Time) on Thursday, June 12, 2025. You can register here :

https://zoom.us/webinar/register/WN_P4nfq0iOSamSBEiaDZ0IZA#/registration

Please feel free to reach out to me with any questions or comments, at samir@askeladdencapital.com or (682) 553-8302. We look forward to earning your vote.

Cordially,

Samir Patel

Founder and Portfolio Manager, Askeladden Capital

Samir Patel, Askeladden Capital Management LLC, Jeff Sands, Shawn Kravetz, Ryan Oviatt and Boyd Roberts (collectively the “Participants”) filed a definitive proxy statement and accompanying proxy card with the SEC on May 20, 2025, as amended on May 21, 2025, to be used in soliciting proxies in connection with the 2025 annual meeting of shareholders (the “Annual Meeting”) of AstroNova, Inc. (the “Company”). All shareholders of the Company are advised to read the Proxy Statement and other documents related to the solicitation of proxies, each in connection with the Annual Meeting, by the Participants, as they contain important information, including additional information related to the Participants, including a description of their direct or indirect interests by security holdings or otherwise. The Proxy Statement and an accompanying GOLD proxy card will be furnished to some or all of the Company’s stockholders and is, along with other relevant documents, available at no charge on the SEC website at http://www.sec.gov, or by contacting Samir Patel at 1452 Hughes Road, Suite 200 #582, Grapevine, TX, 76051.

---

[1] Q4 FY2024 and Q4 FY2025 Earnings Release.

[2] FY2025 Form 10-K filed April 15, 2025.

[3] Stock price data from YCharts.

[4] FY2025 Form 10-K, page 24.

[5] AstroNova Form 10-K for FY2025. Impairment discussed on page 11; purchase price discussed on page 15.

[6] MTEX Acquisition Announcement and Conference Call Transcript (May 9, 2024) and FY2025 Form 10-K filed April 15, 2025.

[7] Form 8-K Earnings filed March 21, 2025.

[8] FY2025 Form 10-K, page 24.

[9] Spruce Power Holding Corp Definitive Proxy, page 10.

[10] Profire Energy (PFIE) SC14D9 dated December 3, 2024. Section “Background of the Offer and the Merger” on pages 9 – 16. https://www.sec.gov/Archives/edgar/data/1289636/000110465924124898/tm2429518-1_sc14d9.htm

[11] “The American work culture focuses on ambition… in Portugal, there is a more collective approach to work and less pressure… [people] tend to place greater importance on personal well-being, family time, and life outside of work.” LXUS (Corporate Relocation service provider.) https://www.lxusportugal.com/blog-lxusportugal/cultural-comparison-between-the-usa-and-portugal

[12] Letter accompanying AstroNova’s definitive proxy statement, filed May 19, 2025.

[13] “TransDigm raises offer price for Servotronics to $47/share.” Seeking Alpha. May 29, 2025. https://seekingalpha.com/news/4453416-transdigm-raises-offer-price-for-servotronics-to-47-share

[14] “Transdigm to Acquire Servotronics For About $110 million.” Nasdaq. May 19, 2025. https://www.nasdaq.com/articles/transdigm-acquire-servotronics-about-110-mln

[15] Per data sources such as Seeking Alpha, ALOT shares closed at $9.12 on May 20, 2025. The company’s recent definitive proxy statement, filed May 19, 2025, discloses a recent sharecount of approximately 7.6 million shares, for a market cap of approximately $69 million as of that date. AstroNova’s Form 10-K filed April 15, 2025 discloses $20.9 million outstanding on the revolving credit facility, $6.1 million in current long-term debt, $0.6 million in short-term debt, and $19 million in long-term debt, for a total of $46.6 million in gross debt. The same Form 10-K disclosed $5 million of cash and equivalents, making net debt $41.6 million. The sum of $41 million and $69 million is approximately $110 million.

[16] Form 10-K for Servotronics SVT filed March 17, 2025.

[17] AstroNova Form 10-K for FY2025, filed April 15, 2025. Page 24.

[18] Data from YChart

Samir Patel
samir@askeladdencapital.com
(682) 553-8302

SOURCE: Askeladden Capital Management LLC

View the original press release on ACCESS Newswire

INDIANAPOLIS, INDIANA / ACCESS Newswire / June 2, 2025 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network anchored by patented AI-powered Arrive Points™, announced today that Laurie Tucker, has joined its Board of Directors. Tucker, a former Senior Vice President of Marketing at FedEx and an experienced board member, brings invaluable logistics and strategic expertise to Arrive AI.

View the original press release on ACCESS Newswire

HESPERIA, CA / ACCESS Newswire / June 2, 2025 / 5E Advanced Materials, Inc.(NASDAQ:FEAM)(ASX:5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, announced today that Chief Executive Officer Paul Weibel will present at the MicroCap Rodeo Conference on Wednesday, June 4, 2025, in New York City. In addition to the live presentation, management will host one-on-one meetings with investors registered to attend the event.

The presentation will begin at 2:30 p.m. ET on June 4. Investors interested in viewing the webcast can register here. The webcast and associated presentation can also be accessed through the investor section of the Company’s website at: https://investors.5eadvancedmaterials.com/events-presentations.

For more details about the MicroCap Rodeo Conference in New York City, please visit https://www.microcaprodeo.com/.

About 5E Advanced Materials, Inc.

5E Advanced Materials, Inc. (NASDAQ:FEAM)(ASX:5EA) is focused on becoming a vertically integrated global leader and supplier of boron specialty and advanced materials, complemented by lithium co-product production. The Company’s mission is to become a supplier of these critical materials to industries addressing global decarbonization, food and domestic security. Boron and lithium products will target applications in the fields of electric transportation, clean energy infrastructure, such as solar and wind power, fertilizers, and domestic security. The business strategy and objectives are to develop capabilities ranging from upstream extraction and product sales of boric acid, lithium carbonate and potentially other co-products, to downstream boron advanced material processing and development. The business is based on our large domestic boron and lithium resource, which is located in Southern California and designated as Critical Infrastructure by the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical fact included in this press release regarding the Company’s business strategy, plans, goals, and objectives, including regarding the anticipated changes to the Company’s board of directors and management and anticipated benefits, are forward-looking statements. When used in this press release, the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “budget,” “target,” “aim,” “strategy,” “plan,” “guidance,” “outlook,” “intent,” “may,” “should,” “could,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on the Company’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. We caution you that these forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which are beyond our control, incident to the extraction of the critical materials we intend to produce and advanced materials production and development. These risks include, but are not limited to: our limited operating history in the borates and lithium industries and no revenue from our proposed extraction operations at our properties; our need for substantial additional financing to execute our business plan and our ability to access capital and the financial markets; our status as an exploration stage company dependent on a single project with no known Regulation S-K 1300 mineral reserves and the inherent uncertainty in estimates of mineral resources; our lack of history in mineral production and the significant risks associated with achieving our business strategies, including our downstream processing ambitions; our incurrence of significant net operating losses to date and plans to incur continued losses for the foreseeable future; risks and uncertainties relating to the development of the Fort Cady project, including our ability to timely and successfully complete our proposed Commercial Scale Boron Facility; our ability to obtain, maintain and renew required governmental permits for our development activities, including satisfying all mandated conditions to any such permits; the implementation of and expected benefits from certain reduced spending measures, and other risks and uncertainties set forth in our filings with the U.S. Securities and Exchange Commission from time to time. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove incorrect, our actual results and plans could differ materially from those expressed in any forward-looking statements. These risks are not exhaustive and the information in this press release may be subject to additional risks. No representation or warranty (express or implied) is made as to, and no reliance should be place on, any information, including projections, estimates, targets, and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions, or misstatements contained herein. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as to the date of this press release.

For additional information regarding these various factors, you should carefully review the risk factors and other disclosures in the Company’s Form 10-K filed on September 9, 2024 and subsequent filings with the U.S. Securities and Exchange Commission throughout the year, as well as in its filings under the Australian Securities Exchange. Any forward-looking statements are given only as of the date hereof. Except as required by law, 5E expressly disclaims any obligation to update or revise any such forward-looking statements. Additionally, 5E undertakes no obligation to comment on third party analyses or statements regarding 5E’s actual or expected financial or operating results or its securities.

For further information contact:

Joseph Caminiti or Nathan Skown
Alpha IR Group
FEAM@alpha-ir.com
Ph: +1(312) 445-2870

SOURCE: 5E Advanced Materials, Inc.

View the original press release on ACCESS Newswire

VANCOUVER, BC / ACCESS Newswire / June 2, 2025 / CoTec Holdings Corp. (TSXV:CTH) (“CoTec” or the “Company“) today announces that it has received the approval of the TSX Venture Exchange (the “TSXV“) for the conversion component of its convertible loan agreement dated November 25, 2024 (as amended, the “Convertible Loan Agreement“) with Kings Chapel International Limited (“Kings Chapel“), previously disclosed in the Company’s news releases dated November 25, 2024 and February 28, 2025.

The outstanding principal amount under the Convertible Loan Agreement as at May 30, 2025 is $6,351,387 and $664,668 in interest has accrued thereunder.

The outstanding principal amount under the Convertible Loan Agreement will be converted into common shares of the Company (“Common Shares“) (i) at any time at Kings Chapel’s election, at a price of CAD$0.75 per Common Share, and (ii) automatically at a price of CAD$0.75 per Common Share, on the first day on which the volume weighted average trading price of the Common Shares on the principal stock exchange on which the Common Shares are then traded over the immediately preceding 15 trading days is equal to or greater than CAD$1.00. No conversion of the outstanding principal amount will occur to the extent that, after giving effect to the conversion, Kings Chapel, its affiliates and any person with whom Kings Chapel or its affiliates would own more than 49% of the outstanding Common Shares.

Kings Chapel is an existing insider and Control Person (as defined by TSX Venture Exchange (“TSXV“) Rules) of the Company. Julian Treger, a director of the Company and its Chief Executive Officer, is a beneficiary of a family trust associated with Kings Chapel. As a result, the execution of the Convertible Loan Agreement was a related party transaction subject to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI61-101“). The execution of the Convertible Loan Agreement was exempt from the formal valuation requirements of MI 61-101 pursuant to subsection 5.5(b) of MI 61-101 because the Common Shares are listed only on the TSXV and is exempt from the minority shareholder approval requirements of MI 61-101 pursuant to subsection 5.7(1)(a) of MI 61-101 because the fair market value of neither the Convertible Loan Agreement nor the Common Shares issuable pursuant to the conversion of the outstanding principal amount under the Convertible Loan Agreement exceed 25% of the Company’s market capitalization as determined in accordance with MI 61-101.

All securities issuable in connection with the Convertible Loan Agreement will be subject to a statutory hold period of four months plus a day from the date of the Convertible Loan Agreement in accordance with applicable securities legislation in Canada.

About CoTec

CoTec is a publicly traded investment issuer listed on the TSXV and the OTCQB and trades under the symbol CTH and CTHCF respectively. CoTec is a forward-thinking resource extraction company committed to revolutionizing the global metals and minerals industry through innovative, environmentally sustainable technologies and strategic asset acquisitions. With a mission to drive the sector toward a low-carbon future, CoTec employs a dual approach: investing in disruptive mineral extraction technologies that enhance efficiency and sustainability while applying these technologies to undervalued mining assets to unlock their full potential. By focusing on recycling, waste mining and scalable solutions, the Company accelerates the production of critical minerals, shortens development timelines, and reduces environmental impact. CoTec’s strategic model delivers low capital requirements, rapid revenue generation and high barriers to entry, positioning it as a leading mid-tier disruptor in the commodities sector.

For more information, please visit www.cotec.ca.

For further information, please contact:

Braam Jonker – (604) 992-5600

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE: CoTec Holdings Corp.

View the original press release on ACCESS Newswire